NRIX icon

Nurix Therapeutics
NRIX

Overview Fund Activity

171 hedge funds and large institutions have $1.52B invested in Nurix Therapeutics in 2024 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 66 increasing their positions, 57 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
171
Holders Change
-2
Holders Change %
-1.16%
% of All Funds
2.47%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
28
Increased
66
Reduced
57
Closed
30
Calls
$1.84M
Puts
$1.21M
Net Calls
+$628K
Net Calls Change
+$1.86M

Top Buyers

1
CC
1
Commodore Capital
New York
$37.1M
2
Pictet Asset Management
2
Pictet Asset Management
Switzerland
$40.2M
3
BC
3
Boxer Capital
California
$12.7M
4
Sumitomo Mitsui Trust Group
4
Sumitomo Mitsui Trust Group
Japan
$12.4M
5
NAMA
5
Nikko Asset Management Americas
New York
$12.4M

Top Sellers

1
SCM
1
Soleus Capital Management
Connecticut
$23.9M
2
RCM
2
RA Capital Management
Massachusetts
$0
3
Millennium Management
3
Millennium Management
New York
$4.98M
4
State Street
4
State Street
Massachusetts
$53.3M
5
Nuveen Asset Management
5
Nuveen Asset Management
Illinois
$15.1M
Name Holding Trade Value Shares
Change 		Shares
Change %
BC
26
Boxer Capital
California
$12.7M +$12.7M +563,067 New
Sumitomo Mitsui Trust Group
27
Sumitomo Mitsui Trust Group
Japan
$12.4M +$12.4M +553,251 New
NAMA
28
Nikko Asset Management Americas
New York
$12.4M +$12.4M +552,602 New
Goldman Sachs
29
Goldman Sachs
New York
$11.5M +$1.09M +48,714 +10%
Charles Schwab
30
Charles Schwab
California
$11.5M -$2.51M -111,684 -18%
Dimensional Fund Advisors
31
Dimensional Fund Advisors
Texas
$11.3M -$2.28M -101,564 -17%
PHP
32
Parkman Healthcare Partners
Connecticut
$9.86M -$802K -35,708 -8%
VPC
33
Vestal Point Capital
New York
$9.55M -$1.69M -75,000 -15%
OM
34
Opaleye Management
Massachusetts
$9.44M +$24.1K +1,072 +0.3%
Invesco
35
Invesco
Georgia
$9.29M +$1.08M +48,042 +13%
SSA
36
Schonfeld Strategic Advisors
New York
$7.99M -$1.72M -76,687 -18%
Lord, Abbett & Co
37
Lord, Abbett & Co
New Jersey
$7.88M +$7.88M +350,640 New
WP
38
Woodline Partners
California
$7.57M +$786K +34,992 +12%
PSC
39
Patient Square Capital
California
$7.32M +$7.32M +325,789 New
ACH
40
ArrowMark Colorado Holdings
Colorado
$7.07M – – –
Bessemer Group
41
Bessemer Group
New Jersey
$6.88M +$1.12K +50 +0%
RPAM
42
Rhenman & Partners Asset Management
Sweden
$6.74M +$2.82M +125,607 +72%
Primecap Management
43
Primecap Management
California
$6.52M – – –
IC
44
Ikarian Capital
Texas
$5.84M -$4.06M -180,500 -41%
Renaissance Technologies
45
Renaissance Technologies
New York
$5.54M -$1.74M -77,600 -24%
Voloridge Investment Management
46
Voloridge Investment Management
Florida
$5.42M -$2.11M -93,924 -28%
WFA
47
WestHill Financial Advisors
California
$5.36M -$1.01M -45,000 -16%
Millennium Management
48
Millennium Management
New York
$4.98M -$8.49M -377,905 -63%
Qube Research & Technologies (QRT)
49
Qube Research & Technologies (QRT)
United Kingdom
$4.82M +$2.68M +119,304 +125%
SC
50
Stempoint Capital
New York
$4.56M -$5.8K -258 -0.1%
1
2
3 4 5